TAIHO PHARMACEUTICAL CO., LTD is a Japanese pharmaceutical company that specializes in the development, manufacture, and sale of prescription drugs. The company was founded in 1943 and is headquartered in Tokyo, Japan. It operates in the Specialty Pharma sector, which focuses on developing drugs for specific diseases or medical conditions.

TAIHO PHARMACEUTICAL CO., LTD is committed to sustainability and decarbonisation. The company recognizes that climate change is one of the most significant challenges facing the world today, and it is taking steps to reduce its carbon footprint. TAIHO PHARMACEUTICAL CO., LTD has set a target to reduce its greenhouse gas emissions by 30% by 2030, compared to its 2013 baseline.

One of the ways TAIHO PHARMACEUTICAL CO., LTD is working towards decarbonisation is through its corporate energy strategy. The company is investing in renewable energy sources, such as solar and wind power, to reduce its reliance on fossil fuels. TAIHO PHARMACEUTICAL CO., LTD has installed solar panels at its facilities in Japan and is exploring the use of wind power in the future.

TAIHO PHARMACEUTICAL CO., LTD is also pursuing corporate power purchase agreements (PPAs) to support its renewable energy goals. A corporate PPA is a long-term contract between a company and a renewable energy provider, which guarantees a fixed price for energy over a set period. By entering into a corporate PPA, TAIHO PHARMACEUTICAL CO., LTD can support the development of new renewable energy projects and reduce its carbon footprint.

In addition to its renewable energy efforts, TAIHO PHARMACEUTICAL CO., LTD is also focused on reducing its overall energy consumption. The company has implemented energy-saving measures at its facilities, such as upgrading lighting systems and HVAC systems. TAIHO PHARMACEUTICAL CO., LTD is also working to improve the energy efficiency of its manufacturing processes, which can be energy-intensive.

TAIHO PHARMACEUTICAL CO., LTD's commitment to sustainability extends beyond its energy strategy. The company is also focused on reducing waste and conserving resources. TAIHO PHARMACEUTICAL CO., LTD has implemented a waste reduction program at its facilities, which includes recycling and reusing materials whenever possible. The company is also working to reduce its water consumption and has implemented water-saving measures at its manufacturing facilities.

TAIHO PHARMACEUTICAL CO., LTD's sustainability efforts are not only good for the environment, but they also make good business sense. By reducing its energy consumption and waste, the company can lower its operating costs and improve its bottom line. Additionally, TAIHO PHARMACEUTICAL CO., LTD's commitment to sustainability can help attract and retain customers who are increasingly concerned about the environmental impact of the products they purchase.

In conclusion, TAIHO PHARMACEUTICAL CO., LTD is a Japanese pharmaceutical company that operates in the Specialty Pharma sector. The company is committed to sustainability and decarbonisation and is taking steps to reduce its carbon footprint. TAIHO PHARMACEUTICAL CO., LTD is investing in renewable energy sources, pursuing corporate PPAs, and implementing energy-saving measures at its facilities. The company is also focused on reducing waste and conserving resources. TAIHO PHARMACEUTICAL CO., LTD's sustainability efforts not only benefit the environment but also make good business sense.